- Research Plus
- Portfolios & Watchlists
- Charting
- Screening Tools
- Visual Tools
- Education Guides
- UK Shares
- Funds
- International Shares
- Gilts
- Currencies
- Commodities
- Company Diary
- Free Brochures
- ETF Centre
- Real Time
Hemogenyx Pharmaceuticals (HEMO)
Sector:
Pharma and Biotech
- Change Today: 0.000p
- 52 Week High: 3.96p
- 52 Week Low: 0.88p
- Currency: UK Pounds
- Shares Issued: 1,401.82m
- Volume: 0
- Market Cap: £16.82m
- RiskGrade: 340
- Beta: 0.73
Trade now with Barclays Stockbrokers
Update - 
Latest ShareCast News
Hemogenyx shares boosted by partner investment
By Benjamin Chiou
Date: Wednesday 02 Oct 2024
(Sharecast News) - Shares in Hemogenyx Pharmaceuticals jumped on Wednesday after the clinical-stage biopharmaceutical group announced another investment from Prevail Partners via a share subscription at a significant premium to the current market value.
Hermogenyx shares soar on new partnership with Prevail Partners
By Benjamin Chiou
Date: Monday 18 Sep 2023
(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.
Hemogenyx signs another deal with unnamed global pharma company
By Josh White
Date: Wednesday 23 Oct 2019
(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.
HEMO Market Data
| Currency | UK Pounds |
| Share Price | 1.20p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 3.96p |
| 52 Week Low | 0.88p |
| Volume | 0 |
| Shares Issued | 1,401.82m |
| Market Cap | £16.82m |
| Beta | 0.73 |
| RiskGrade | 340 |
HEMO Star Ratings
| Value |
    |
|---|
| Price Trend |
  |
|---|
| Income |  |
|---|
| Growth | |
|---|
HEMO Dividends
| No dividends found |
You are here: research
10 Lower Thames St,
London EC3R 6EN